Project Grant K23HL177329
- Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded The Johns Hopkins University a Project Grant totaling $120,363 under the Cardiovascular Diseases Research program (CFDA 93.837), effective August 18, 2025, through July 31, 2030. This K24 Mid-Career Investigator Award provides resources, training, and protected time to strengthen and expand Dr. Michelle Eakin's mentoring program focused on patient-oriented implementation science in asthma care. The award...
- Federal Project Grant Award Summary Connecticut Children's Medical Center received a $156,340 project grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), awarded June 15, 2025, with completion targeted by May 31, 2030. This Mentored Patient-Oriented Research Career Development (K23) award supports Dr. Siddika Mulchan's five-year research program investigating provider-focused interventions to improve health outcomes...
- Federal Project Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded Yale University a K23 Career Development Grant totaling $389,444 (awarded August 15, 2025, with completion by July 31, 2030) under the Cardiovascular Diseases Research program (CFDA 93.837). This grant supports Dr. James T. Nugent, an Instructor of Pediatrics at Yale School of Medicine, in developing into an independent physician-scientist focused on pediatric hypertension research. The primary...
- Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), awarded $169,992 to the University of Colorado-Denver on September 18, 2025, to support a mixed-methods research study titled "Start Strong." This K01 mentored career development award funds research investigating optimal antihypertensive medication initiation strategies and will generate evidence for a future pragmatic trial testing a...
- Federal Project Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded a K23 Development Grant of $345,600 to Columbia University's Health Sciences Division, with performance extending from July 20, 2025, through June 30, 2030. Under the Cardiovascular Diseases Research program (CFDA 93.837), this award supports Dr. Michael Brener's development as an independent investigator in valvular heart disease research. The grant funds research, training, and mentorship designed...
- Federal Project Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded $133,436 to The Trustees of Columbia University in the City of New York (Health Sciences Division) on August 1, 2025, under the Cardiovascular Diseases Research program (CFDA 93.837). This K99/R00 career development award supports Dr. Sri Karthika Shanmugam's transition to an independent academic position through a structured two-phase research and training program extending through July 31, 2027....
- This K23 mentored career development award of $165,353 was obligated on September 25, 2025, by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) to Massachusetts General Hospital. The grant supports a structured research and training initiative to investigate the effects of severe obesity on regional lung perfusion in patients experiencing acute hypoxemic respiratory failure (AHRF). The research deliverables include: (1) a...
- Federal Grant Award Summary Duke University's Office of Research Administration received a $136,646 K01 Career Development Award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), effective September 19, 2025, through August 31, 2030. This award funds an observational research study designed to identify sex differences in physical activity (PA) participation, barriers, and predictors among individuals during and...
- Federal Project Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded The Johns Hopkins University a $392,233 Project Grant, effective August 1, 2025 through May 31, 2030, under the Cardiovascular Diseases Research program (CFDA 93.837). Dr. Lee Goeddel, a cardiac anesthesiologist and intensivist, will conduct structured clinical research to investigate the relationship between cardiac output, renal perfusion, and acute kidney injury (AKI) development in cardiac...
- Federal Grant Award Summary New York University School of Medicine received a $248,999 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), effective July 14, 2025, with completion scheduled for June 30, 2028. This K99/R00 Pathway to Independence Award supports the development and evaluation of time-restricted eating (TRE) as a weight loss maintenance strategy. The award funds a pilot randomized...
Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded a Career Development Grant (K23) totaling $201,744 to New York University's Long Island School of Medicine on June 5, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837). The award supports Dr. Arabadjian's development from a mentored researcher into an independent investigator through a comprehensive career development plan spanning clinical trial design, implementation science, cardiovascular disease (CVD) prevention, and leadership training. Under the guidance of a multidisciplinary mentoring team, Dr. Arabadjian will complete structured training in community-based health interventions and CVD prevention while simultaneously pilot-testing a context-specific intervention addressing cardiovascular health promotion among socially vulnerable mothers of young children. The primary deliverable is a 10-week community health worker-led intervention called MOM.HEALTH, which will recruit 50 mothers from two childcare centers serving low-income families in New York City. The intervention comprises lifestyle counseling delivered through eight individual phone sessions and two in-person group sessions, designed to address the American Heart Association's Life's Essential 8 cardiovascular health components and stress management strategies. By leveraging childcare centers as engagement platforms, this implementation science approach targets a high-risk population with elevated lifetime CVD risk due to adverse social determinants, unique caregiving stressors, and low preventive care utilization. The project concludes on February 28, 2031.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $201.7k | 6/8/26 |